Order Bellast® Plus for Clinics

Bellast® Plus is a sterile cross-linked hyaluronic acid dermal filler with lidocaine 0.3% in a prefilled 1 mL syringe. Licensed clinics, med spas, and healthcare professionals can order Bellast Plus dermal filler for professional injection workflows that require a cohesive HA gel, single-use presentation, and clear lot-level documentation.

The formulation contains hyaluronic acid 20 mg/mL and is intended for trained injectors working within established aesthetic protocols. Its practical value is the combination of a moldable gel profile, integrated anesthetic, and clinic-friendly unit format for facial contouring and fold refinement.

Bellast Plus 1 mL Syringe and Ordering Details

Bellast Plus 1ml is supplied as one sterile, prefilled syringe for single-patient use. The 1.0 mL x 1 syringe format supports straightforward room setup, inventory counting, and reorder planning for practices that schedule filler appointments across multiple treatment days.

Licensed accounts can sign in to view current Bellast Plus price information and clinic-specific ordering terms. Pricing may depend on account status, order quantity, and contract arrangements, so procurement teams should use the account dashboard for the current unit cost rather than relying on informal market references.

Each unit includes visible lot and expiry details to support intake checks and treatment-room documentation. Bellast Plus wholesale ordering is intended for professional use, and clinic documentation may be required before an account can complete purchases. Med Wholesale Supplies serves licensed healthcare accounts with brand-name medical products sourced through vetted distributors and verified supply channels.

What Bellast Is and How the HA Gel Works

Bellast® Plus is made with non-animal hyaluronic acid that has been cross-linked with BDDE. Hyaluronic acid is a water-binding polysaccharide found naturally in connective tissue. In dermal filler use, the HA gel adds volume within the soft tissue matrix and gradually breaks down through normal metabolic processes.

The product’s 20 mg/mL HA concentration provides the volumizing backbone, while cross-linking helps shape cohesivity and resistance to deformation after placement. The integrated lidocaine 0.3% is included to support comfort during injection, which can help clinics streamline procedure flow when the anesthetic profile fits internal protocols.

Residual BDDE is kept low to support product purity, and the endotoxin level is listed as under 0.5 EU/mL. These specifications are relevant for clinics that review filler selection through procurement, medical director, or quality-assurance processes. For practices building a consistent product family, the Bellast brand portfolio can help align adjacent syringe choices with injector preference and treatment planning.

Professional Applications and Treatment-Room Fit

Clinical teams typically position this Bellast HA filler for moderate-to-deep aesthetic corrections that benefit from a cohesive, moldable gel. Use cases may include refinement of nasolabial folds, marionette lines, chin and jawline contour, nasal definition, or midface shaping when the injector’s training, patient assessment, and local protocols support those choices.

Bellast Plus injectable handling is designed for precision placement by trained professionals. The gel’s smooth extrusion and even distribution may help experienced injectors maintain controlled passes, contour transitions, and predictable molding during treatment. Individual technique, anatomy, injection depth, and post-procedure assessment remain clinical decisions.

Clinics offering a broader Bellast range may pair this product with lighter or softer presentations for different tissue planes and aesthetic goals. For formulation-selection context within the same family, the article on natural-looking volume with Bellast filler can support internal discussion without replacing product training or medical oversight.

Key Features for Clinic Procurement

• Cross-linked HA gel with balanced cohesivity for contour control.
• Non-animal hyaluronic acid that is biocompatible and gradually resorbable.
• Lidocaine 0.3% integrated into the gel for in-procedure comfort.
• HA concentration of 20 mg/mL for volumizing and fold refinement.
• Low residual BDDE to support a purity-focused formulation profile.
• Low endotoxin specification of under 0.5 EU/mL.
• Sterile, single-use 1 mL prefilled syringe for professional injection.
• Smooth extrusion designed for consistent injection force.
• Visible lot and expiry details for receiving and treatment records.

Quick tip: Record lot, expiry, and syringe count during receiving so clinical and procurement records match before treatment days.

Composition, Ingredients, and Verification Points

The active component is cross-linked hyaluronic acid in a buffered gel. Lidocaine is included as the anesthetic component at 0.3%. BDDE is used as the cross-linking agent, with low residual levels in the final product profile.

At intake, clinic staff should confirm the labeled product name, pack size, lot number, expiry date, HA concentration, lidocaine content, and package integrity. The notation Bellast Plus 1 x 1ml may appear in ordering or inventory systems, so teams should align internal naming with the physical syringe label to avoid pick errors.

The syringe is sterile and intended for single use. Do not use a unit if the sterile barrier appears compromised, the label cannot be verified, or the product does not match the intended treatment plan. Any product concern should be handled according to the clinic’s device complaint and quarantine procedure.

Benefits in Practice

Bellast® Plus supports clinic workflows that value a cohesive HA filler, integrated lidocaine, and a straightforward unit configuration. The gel structure is designed for stable contouring in appropriately selected facial areas, while the prefilled syringe helps simplify setup and room turnover.

Consistent rheology across stock can help trained injectors maintain familiar handling during multi-area sessions. That does not make outcomes automatic; assessment, injection technique, volume choice, and follow-up practices still determine whether a result fits the treatment objective.

For procurement staff, the single-syringe presentation makes usage tracking easier than mixed or multi-unit configurations. A predictable unit format can also help forecast reorder timing, especially for clinics that dedicate specific procedure blocks to filler appointments.

Safety, Precautions, and Professional Administration

Dermal fillers should be administered only by appropriately trained healthcare professionals who understand facial anatomy, injection depth, vascular risk, aseptic technique, and emergency response protocols. Hyaluronic acid fillers can cause expected local reactions such as swelling, redness, bruising, tenderness, firmness, itching, or temporary discomfort at the injection site.

Serious complications are uncommon but can include infection, nodules, inflammatory reactions, tissue compromise, vascular occlusion, visual disturbance, or other events requiring urgent clinical management. Clinics should maintain protocols for patient screening, informed consent, aftercare instructions, adverse-event documentation, and escalation when symptoms suggest vascular or infectious complications.

Selection should account for allergies, active skin infection or inflammation in the treatment area, prior filler history, immune or bleeding considerations, relevant medications, and the patient’s aesthetic goals. Lidocaine content also matters for patients with known sensitivity to local anesthetics. Follow product labeling, professional training, and medical director guidance when determining whether Bellast Plus syringe use is appropriate.

Storage, Handling, and Inventory Control

Store and handle Bellast® Plus according to the manufacturer’s labeling and clinic standard operating procedures. Keep the syringe in its original packaging until treatment setup, protect the sterile barrier, and avoid unnecessary handling that could compromise traceability or product integrity.

Receiving staff should reconcile the purchase order, packing slip, lot numbers, and expiry dates before stock enters the treatment inventory. Temperature-controlled handling when required and tracked US delivery can support routine clinic receiving processes, but internal storage checks remain the responsibility of the receiving practice.

Use first-expiring units first when clinically appropriate, and separate any product with damaged packaging, unclear labeling, or unexpected appearance. For multi-location practices, centralizing lot records can simplify follow-up if a product notice or internal audit requires rapid tracing.

How to Evaluate Bellast Plus Against Related Fillers

When clinics ask whether Bellast filler is a good fit, the practical answer depends on treatment area, injector technique, desired gel behavior, patient selection, and portfolio strategy. Bellast® Plus is a cohesive 20 mg/mL HA filler with lidocaine, so it may suit practices looking for a mid-to-deep correction option within a broader HA filler range.

Bellast Plus vs Juvederm-style comparisons should focus on rheology, labeled use context, handling preference, procurement needs, and clinician familiarity rather than broad claims of superiority. Different HA fillers may feel different during extrusion, molding, and tissue integration. Injector training and product familiarity often matter as much as the brand name.

For adjacent options, practices may review Revofil Plus for mid-depth volumizing decisions, or consider Bellast L when a lighter Bellast-family syringe better fits the treatment plan. Clinics that need a softer Bellast-family presentation can also assess Bellast Soft L 1 mL for appropriate use cases.

Related Bellast Names and Portfolio Planning

Searches for Bellast Ultra Plus, Bellast Ultra Plus 1ml, or Bellast Ultra Plus syringe may reflect interest in higher-density or adjacent Bellast-family products. Those terms should not be treated as interchangeable with Bellast® Plus unless the exact package label, concentration, and clinical protocol match the product being ordered.

Procurement teams should maintain a clean formulary naming system that distinguishes Bellast® Plus from Bellast L, Bellast Soft L, and any Ultra-labeled products. This reduces the chance of selecting the wrong syringe for a scheduled treatment area or injector preference.

A standardized filler matrix can list each product’s HA concentration, lidocaine status, syringe volume, intended tissue plane, injector notes, reorder threshold, and storage location. Keeping that matrix current is especially useful for clinics rotating multiple HA products across providers.

Clinic Ordering, Documentation, and Logistics

Licensed healthcare accounts can add Bellast® Plus to procurement lists and complete ordering after professional-use account requirements are satisfied. Account dashboards can help teams view current pricing, repeat prior orders, and reconcile received units against packing records.

For US distribution planning, align order timing with scheduled filler sessions, expected weekly usage, and internal receiving coverage. Avoid building appointment capacity around unverified inventory; confirm physical stock, lot information, and expiry before assigning units to the treatment room.

Large practices may benefit from branch-level reorder thresholds and a shared record of preferred alternatives. If a clinic needs to adjust the filler plan because of allocation or internal protocol changes, the decision should involve the treating professional and medical leadership rather than procurement alone.

Authoritative Sources

Independent references can support clinic education on dermal filler risks, soft tissue filler classification, and hyaluronic acid background. They should supplement, not replace, product labeling, hands-on training, and internal medical protocols.

• FDA: Dermal Fillers and Soft Tissue Fillers
• NIH PubChem: Hyaluronic Acid

Ready to add this item to your clinic formulary? Sign in to view account pricing, confirm professional-use ordering requirements, and plan replenishment around your treatment schedule.

This content is for informational purposes only and is not a substitute for professional medical advice.